These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36537696)

  • 1. Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A.
    Bullano M; Cool C; Schultz BG; Durgapal S; Sacks N; Liu Y; Kee R; Batt K
    Expert Rev Pharmacoecon Outcomes Res; 2023 Feb; 23(2):225-230. PubMed ID: 36537696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic analysis of different treatments for bleeding in patients with acquired haemophilia.
    Kim CH; Simmons SC; Wang D; Najafzadeh P; Azad A; Pham HP
    Vox Sang; 2020 Apr; 115(3):192-199. PubMed ID: 31879973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired haemophilia and haemostatic control with recombinant porcine factor VIII: case series.
    Campbell S; Mason J; Prasad R; Ambrose H; Hunt S; Tran H
    Intern Med J; 2021 Feb; 51(2):215-219. PubMed ID: 32043744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant porcine sequence factor VIII (rpFVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients.
    Tarantino MD; Cuker A; Hardesty B; Roberts JC; Sholzberg M
    Haemophilia; 2017 Jan; 23(1):25-32. PubMed ID: 27511890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term efficacy of recombinant porcine factor VIII in patients with factor VIII inhibitors.
    Abou-Ismail MY; Vuyyala S; Prunty J; Schmaier AH; Nayak L
    Haemophilia; 2020 Jul; 26(4):601-606. PubMed ID: 32338423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
    Bowyer A; Gray E; Lowe A; Murphy P; Platton S; Riddell A; Chowdary P; Lester W; Jenkins PV
    Haemophilia; 2022 May; 28(3):515-519. PubMed ID: 35279922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 Study.
    Türkantoz H; Königs C; Knöbl P; Klamroth R; Holstein K; Huth-Kühne A; Heinz J; Eichler H; Tiede A
    J Thromb Haemost; 2020 Jan; 18(1):36-43. PubMed ID: 31448877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
    Beckman JD; Holle LA; Wolberg AS
    J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort.
    Ellsworth P; Chen SL; Kasthuri RS; Key NS; Mooberry MJ; Ma AD
    Blood Adv; 2020 Dec; 4(24):6240-6249. PubMed ID: 33351122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand.
    Mehta DA; Oladapo AO; Epstein JD; Novack AR; Neufeld EJ; Hay JW
    J Manag Care Spec Pharm; 2016 Feb; 22(2):149-57. PubMed ID: 27015254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A.
    Bowyer A; Shepherd F; Platton S; Guy S; Kitchen S; Maclean R
    Haemophilia; 2020 Nov; 26(6):1181-1186. PubMed ID: 32997894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenging treatment for refractory acquired haemophilia A complicated with severe severe acute respiratory coronavirus 2 infection.
    Cives TL; Docampo MF; Fernández MTF; Señarís DM; Carmona AH; Pérez-Rodríguez A; Solano MDCGDC; Fernández MFL
    Blood Coagul Fibrinolysis; 2022 Sep; 33(6):342-347. PubMed ID: 35834710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States.
    Neufeld EJ; Sidonio RF; O'Day K; Runken MC; Meyer K; Spears J
    J Med Econ; 2018 Aug; 21(8):762-769. PubMed ID: 29681200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant porcine factor VIII in acquired hemophilia A: Experience from two patients and literature review.
    Hayden A; Candelario N; Moyer G
    Res Pract Thromb Haemost; 2022 Feb; 6(2):e12688. PubMed ID: 35356668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®).
    Zanon E; Pasca S; Spiezia L; Poletto F; Gherardi S; Simioni P
    Thromb Res; 2020 Nov; 195():125-127. PubMed ID: 32683151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIII.
    Barrow RT; Lollar P
    J Thromb Haemost; 2006 Oct; 4(10):2223-9. PubMed ID: 16856973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.
    Fosbury E; Drebes A; Riddell A; Chowdary P
    Ther Adv Hematol; 2017 Sep; 8(9):263-272. PubMed ID: 29051804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study.
    Zhang XH; Zhu XL; Niu T; Sun J; Liu H; Feng R; Yang LH; Wei Q; Ma QH; Wang QM; Feng FE; Fu HX; Mo XD; Lv M; Huang XJ
    Thromb Res; 2015 May; 135(5):835-40. PubMed ID: 25747536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of thrombin generation in hemophilia A plasma by coagulation factor VIII and characterization of antibody-specific inhibition.
    Doshi BS; Gangadharan B; Doering CB; Meeks SL
    PLoS One; 2012; 7(10):e48172. PubMed ID: 23144741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII.
    Nguyen S; Teh P; Zhou J; Chang EY; von Drygalski A
    Case Rep Hematol; 2019; 2019():9026121. PubMed ID: 31559096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.